Related Experiment Video
Updated: Jan 30, 2026

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8+ T Cell Responses
Jun Wang1,2, Yue Li1, Yan Shen1
1Department of Medical Microbiology and Parasitology, Fourth Military Medical University, Xi'an, China.
Abstract:
Cerebral malaria (CM), mainly caused by Plasmodium falciparum (P. f.), is one of the most lethal complications of severe malaria. As immunopathology mediated by brain-infiltrating CD8+ T cells is the major pathogenesis of CM, there is no safe and efficient treatment clinically focused on CD8+ T cells. New methods are needed to protect the host from injury. As evidence has shown that programmed death-1 (PD-1) is one of the most efficient immunomodulatory molecules, we constructed two soluble fusion proteins, PDL1-IgG1Fc and PDL2-IgG1Fc, to enhance PD-1/PDL signaling pathways in innate and adaptive immune cells, including macrophages and CD8+ T cells. Firstly, we confirmed that PD-1 signal pathway deficiency led to higher levels of CD8+ T cell proliferation and shorter survival time in PD-1-deficient (Pdcd1-/-) mice than WT mice. Secondly, PDL1-IgG1Fc-treated mice exhibited a more prolonged survival time than control groups. Moreover, PDL1-IgG1Fc was observed to ameliorate blood-brain barrier (BBB) disruption by limiting the over-reactive CD8+ T cell cytotoxicity during experimental cerebral malaria (ECM). Further studies found thatPDL1-IgG1Fc-treated macrophages showed significant suppression in macrophage M1 polarization and their antigen presentation capability to CD8+ T cells. In conclusion, our results demonstrated that the administration of PDL1-IgG1Fc in the early stage before ECM onset has an obvious effect on the maintenance of immune microenvironment homeostasis in the brain and is deemed a promising candidate for protection against CM in the future.
Insights
Programmed death-1 (PD-1) pathway modulation using PDL1-IgG1Fc protein offers a promising strategy to combat lethal cerebral malaria (CM). This treatment protects the brain by regulating CD8+ T cells and macrophages, improving survival in experimental models.
Area of Science:
- Immunology
- Neuroscience
- Infectious Diseases
Background:
- Cerebral malaria (CM), primarily caused by Plasmodium falciparum, is a life-threatening complication of severe malaria.
- Pathogenesis of CM involves immunopathology driven by CD8+ T cells infiltrating the brain, necessitating novel therapeutic strategies.
- The programmed death-1 (PD-1) pathway is a key regulator of immune responses and a potential therapeutic target.
Purpose of the Study:
- To investigate the therapeutic potential of soluble fusion proteins, PDL1-IgG1Fc and PDL2-IgG1Fc, for treating CM.
- To evaluate the role of the PD-1/PDL signaling pathway in CM pathogenesis and host protection.
- To assess the impact of PDL1-IgG1Fc on immune cell function and blood-brain barrier integrity during experimental CM (ECM).
Main Methods:
- Construction of soluble fusion proteins: PDL1-IgG1Fc and PDL2-IgG1Fc.
- Utilized PD-1-deficient (Pdcd1-/-) and wild-type (WT) mice to study PD-1 pathway function.
- Administered PDL1-IgG1Fc to mice during experimental cerebral malaria (ECM) and assessed survival, immune cell activity, and blood-brain barrier integrity.
Main Results:
- PD-1 pathway deficiency resulted in increased CD8+ T cell proliferation and reduced survival in mice.
- Treatment with PDL1-IgG1Fc significantly prolonged survival in mice with experimental CM (ECM).
- PDL1-IgG1Fc ameliorated blood-brain barrier disruption by suppressing CD8+ T cell cytotoxicity and M1 polarization of macrophages.
Conclusions:
- Enhancing PD-1/PDL signaling via PDL1-IgG1Fc administration is a promising strategy for protecting against CM.
- Early-stage intervention with PDL1-IgG1Fc helps maintain immune homeostasis in the brain during ECM.
- PDL1-IgG1Fc demonstrates potential as a future therapeutic candidate for cerebral malaria treatment.
Related Concept Videos
Tagging and Fusion Proteins
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Repressed Memory
The Unfolded Protein Response
Repressible Operon: trp Operon
Regulation of the Unfolded Protein Response

